ArticleBMC cancer2025

Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.

Hichame Id Boufker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.